A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): A structured summary of a study protocol for a randomized controlled trial

  1. Rodríguez-Rubio, M.
  2. Figueira, J.C.
  3. Acuña-Castroviejo, D.
  4. Borobia, A.M.
  5. Escames, G.
  6. De La Oliva, P.
Revista:
Trials

ISSN: 1745-6215

Año de publicación: 2020

Volumen: 21

Número: 1

Tipo: Artículo

DOI: 10.1186/S13063-020-04632-4 GOOGLE SCHOLAR lock_openAcceso abierto editor
Fuente de los datos: Scopus